NeuroSense Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 08/13/2026 | 108.64 K | $78.22 K | 121.27% | 0.43% |
| INDEPENDENT ADVISOR ALLIANCE | 08/12/2026 | 100.00 K | $72.00 K | 100.00% | 0.39% |
| YORKVILLE ADVISORS GLOBAL, LP | 08/06/2026 | 78.00 K | $56.16 K | 0.00% | 0.31% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 22.78 K | $16.40 K | 0.00% | 0.09% |
| PNC FINANCIAL SERVICES GROUP, INC. | 08/07/2026 | 21.15 K | $15.23 K | 0.00% | 0.08% |
| PATHSTONE HOLDINGS, LLC | 08/13/2026 | 16.53 K | $11.90 K | 0.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 15.87 K | $11.43 K | 0.00% | 0.06% |
| XTX TOPCO LTD | 08/14/2026 | 11.47 K | $8.26 K | 100.00% | 0.05% |
| CREATIVE PLANNING | 08/13/2026 | 11.41 K | $8.22 K | -4.21% | 0.04% |
| HRT FINANCIAL LP | 08/14/2026 | 10.52 K | $7.00 K | 100.00% | 0.04% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 1.00 K | $757 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 255 | $184 | -3.77% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 07/20/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
NeuroSense Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 15 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd. The most heavily invested institutionals were:
UBS Group AG: 108,636
Independent Advisor Alliance: 100,000
Yorkville Advisors Global, LP: 78,000
COMMONWEALTH EQUITY SERVICES, LLC: 22,775
PNC FINANCIAL SERVICES GROUP, INC.: 21,150
Pathstone Holdings, LLC: 16,528
1.56% of NeuroSense Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 397.61 K shares in the last 24 months. This purchase volume represents approximately $333.99 K in transactions.